FDA Inspection 1069823 — Biomat USA, Inc.
The FDA completed an inspection of Biomat USA, Inc. on Sep 27, 2018 in Mobile, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 27, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Mobile, AL (United States)